NSTEMI, short for non-ST-elevation myocardial infarction, is a type of heart attack where blood flow to part of the heart muscle is severely reduced but not completely blocked. Unlike the other major type of heart attack (STEMI), where an artery is fully obstructed, NSTEMI involves a partial blockage that still damages heart tissue. It accounts for a significant share of all heart attacks and requires urgent hospital treatment, though the timeline for intervention is slightly different from a full-blockage heart attack.
How NSTEMI Differs From STEMI
The two types of heart attack are distinguished by what’s happening inside the coronary arteries and what shows up on an ECG (the electrical tracing of your heart). In a STEMI, a blood clot completely blocks a coronary artery. About 84% of STEMI patients have total occlusion of the affected artery. In an NSTEMI, blood flow is restricted but still partially preserved, with roughly 78% of NSTEMI patients maintaining some flow through the affected vessel.
This difference shows up on the ECG. A STEMI produces a distinctive pattern called ST-segment elevation, a specific upward shift in the heart’s electrical signal that tells doctors the full thickness of the heart wall is in danger. An NSTEMI does not produce this pattern. Instead, the ECG may show ST-segment depression, T-wave inversion, or sometimes appear relatively normal. That’s why blood tests are essential for confirming the diagnosis.
One important distinction: NSTEMI patients tend to have more widespread artery disease. While about a third of STEMI patients have disease in just one artery, NSTEMI patients almost always have blockages in multiple vessels. This means the overall condition of the coronary arteries is often more complex, even though the immediate event may seem less dramatic.
What Causes It
The most common cause is a buildup of fatty plaque inside a coronary artery that either ruptures or erodes, triggering a partial blood clot. But NSTEMI has a wider range of causes than STEMI. It can also result from a coronary artery spasm that temporarily narrows the vessel, a blood clot that travels from elsewhere and lodges in a coronary artery, or inflammation of the artery wall itself. In some cases, the heart muscle simply demands more oxygen than the partially narrowed arteries can deliver, such as during a severe infection, a rapid heart rhythm, or a major drop in blood pressure.
Symptoms to Recognize
The classic symptom is chest pain or pressure, often described as a squeezing or heaviness in the center or left side of the chest. This pain may radiate to the jaw, neck, shoulders, or arms. Shortness of breath, sweating, nausea, and lightheadedness are also common.
However, not everyone gets the textbook presentation. Women, particularly those under 45, are significantly more likely to experience a heart attack without chest pain. They may instead notice back pain, extreme fatigue, nausea, or shortness of breath as their primary symptoms. Research from the VIRGO study found that younger women with heart attacks were much more likely than men of the same age to present without chest pain, and they were more likely to attribute their symptoms to anxiety or stress. The absence of chest pain is linked to higher mortality rates in younger patients, likely because it delays treatment.
Older adults also present differently. They’re more likely to show up with signs of heart failure, such as severe shortness of breath and fluid buildup, rather than classic chest pain. Their baseline ECGs are also more likely to be abnormal, which can make it harder to spot new changes caused by the heart attack.
How Doctors Confirm the Diagnosis
Two tools work together to diagnose NSTEMI: the ECG and a blood test for troponin. Troponin is a protein released by damaged heart muscle cells. When troponin levels rise above a threshold (typically above 2 ng/mL for troponin I, though this varies by hospital and test type), it confirms that heart tissue has been injured.
This is actually what separates NSTEMI from unstable angina, a related condition where chest pain occurs at rest but troponin levels stay normal. Unstable angina means the heart is under stress but hasn’t yet sustained measurable damage. Once troponin rises, the diagnosis shifts to NSTEMI. Doctors typically check troponin levels at arrival and again a few hours later to detect a rising pattern.
Treatment and Timing
NSTEMI is treated with a combination of medications and, in most cases, a catheter-based procedure to open the blocked artery. The timing of that procedure depends on how sick you are.
For the highest-risk patients, those with dangerously low blood pressure, life-threatening heart rhythms, or obvious heart failure, guidelines recommend opening the artery within 2 hours of hospital arrival. For other high-risk patients, the standard recommendation is coronary angiography and intervention within 24 hours. Recent research has refined this further, finding that for high-risk NSTEMI patients (based on a clinical risk score), the optimal window for intervention is 3 to 14 hours after admission. Intervening within the first 12 hours was associated with fewer complications over the following 6 months compared to either very immediate or delayed procedures.
Medications start right away. Aspirin is given immediately, along with a second blood-thinning medication to prevent the clot from growing. Blood thinners given through an IV help stabilize the situation until the procedure. After the acute phase, most patients are started on a high-intensity cholesterol-lowering medication to reduce the risk of future events.
Risk Assessment in the Hospital
Doctors use scoring systems to determine how aggressively to treat an NSTEMI. The most widely used is the GRACE score, which calculates your risk based on eight factors: age, heart rate, systolic blood pressure, kidney function, a measure of heart failure severity, whether cardiac arrest occurred, whether cardiac biomarkers are elevated, and ECG changes. A GRACE score above 140 places you in the high-risk category, which influences how quickly you’re taken for a procedure and how closely you’re monitored.
Possible Complications
Most NSTEMI patients recover well with prompt treatment, but complications can occur during the hospital stay. In a large study of NSTEMI patients, the most common serious complications were respiratory failure (4.0%), cardiogenic shock where the heart can’t pump enough blood (3.7%), and cardiac arrest (1.7%). These risks are highest in the first few days and are the reason NSTEMI patients are monitored in a cardiac care unit.
Long-Term Outlook
Survival after NSTEMI depends heavily on how much artery disease is present. For patients with disease in just one vessel, the one-year mortality rate is about 2.4%, and the five-year rate is roughly 10%. For those with three-vessel disease, the numbers are substantially higher: 11.5% at one year and nearly 28% at five years.
The risk of having another heart attack follows a similar pattern. Patients with single-vessel disease have about an 8% chance of a recurrent heart attack within a year, while those with three-vessel disease face a 17% risk in the same timeframe. At five years, recurrence rates range from about 11% to 21% depending on the extent of disease. These numbers underscore why follow-up care, lifestyle changes, and consistent medication use matter so much after an NSTEMI. The initial event is survivable for most people, but managing the underlying artery disease is what determines long-term health.